Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Bio-Rad picks up cytometer platform from Propel
Bio-Rad Laboratories said it acquired Propel Labs high performance analytical flow cytometer platform, with a planned instrument launch from the acquisition later this year.
Flow cytometry is a technique used to identify and sort cells and their components, Hercules, Calif.-based Bio-Rad Laboratories said. Read more
2. CorMatrix wins FDA nod for Tyke neonate cardiac tissue
CorMatrix Cardiovascular said today it won FDA 510(k) clearance for its Tyke biomaterial for use in neonates and infants.
The patch is designed to repair pericardial structures and as an epicardial covering or for intracardiac defects, septal defects, annulus repair, suture-line buttressing. Read more
1. Boston Scientific wins CMS coverage for Watchman LAAC
Boston Scientific said it won coverage from the Centers for Medicare and Medicaid Services for left atrial appendage closure therapies using its Watchman device.
The device and LAAC procedure will be available to patients who meet certain criteria, outlined in the FDA’s final National Coverage Determination, Marlborough, Mass.-based Boston Scientific said. Read more